ArticleOncoTargets and therapy2016

Dose-enhanced combined priming regimens for refractory acute myeloid leukemia and middle-and-high-risk myelodysplastic syndrome: a single-center, retrospective cohort study.

Xiaorong Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.